Introduction
Adiponectin is an adipocyte-secreted hormone and is present in the circulation of healthy humans at high concentrations (Goldstein and Scalia, 2004) . Unlike most other adipocytokines, adiponectin levels decrease in individuals with obesity (Stumvoll et al., 2002) , and adiponectin levels are further reduced in type-II diabetes (Hotta et al., 2000) .
Because adiponectin plays a role in increases in glucose incorporation and insulin sensitization, it is thought that adiponectin is an endogenous anti-diabetic factor (Kadowaki and Yamauchi, 2005) . Moreover, it has been suggested that adiponectin is associated with coronary artery disease, stroke, non-alcoholic steatohepatitis, and several types of cancers (Lam and Xu, 2005; Trujillo and Scherer, 2005; Wang et al., 2007) . In some of these adiponectin-related diseases, dysfunction of the urinary system is recognized as a complication. For example, alterations of urinary bladder smooth muscle tissue are found in diabetes, hypertension, and hyperlipidemia. It has also been reported that adiponectin affects vascular smooth muscle contraction (Ding et al., 2012) . Therefore, we hypothesized that blood adiponectin levels are associated with bladder smooth muscle contractions. However, the association of adiponectin with urinary systems has not been investigated. To understand this association, we hypothesized that the role of adiponectin can be clearly defined under adiponectin-enhanced conditions. In 2006, we established an adiponectin-sense-transgenic (Adip-Sen) mouse (Saito et al., 2006) . We found that plasma adiponectin levels were significantly increased in the Adip-Sen mouse (56.2%) compared with those of the wild type mouse, suggesting a role of adiponectin in regulation of energy homeostasis.
This study aimed to determine if there is an association of adiponectin with bladder smooth muscle contraction, which is an important function of the urinary system, using
Materials and Methods
Generation and maintenance of the transgenic mice. Male Adip-Sen mice (16-24 weeks) and age-matched control (C57Bl/6J) mice were prepared and maintained as described previously (Saito et al., 2006) . Mice were housed at constant room temperature (20 ± 2°C) with 12-h light and dark cycles. Mice were fed standard mouse chow, which included 4.5% fat (Oriental Yeast Corp., Tokyo, Japan). Food and water were available ad libitum and mice grew satisfactorily. Animals were used for experiments at 16-24 weeks of age. This study was approved by the care and use of laboratory animals of the Japanese Pharmacological Society.
Blood collection and plasma biochemical assays. Blood samples were obtained from the inferior vena cava under ether anesthesia. The plasma supernatant was used for the detection of plasma glucose, phospholipids (PL), free fatty acids (FFA), triacylglycerol, and total cholesterol (total-Cho) levels in clinical laboratory tests conducted by SRL Inc. (Tokyo, Japan).
Bladder smooth muscle tissue preparation. Mice were sacrificed by over-treatment of ether, and decapitation and bloodletting were then performed. The urinary bladder was isolated and the tissue was rinsed in physiological salt solution (PSS). Subsequently, fat and connective tissues were removed from bladder tissue strips using cotton and micro-scissors under stereoscopic microscopy. Urothelium was also removed. PSS, which was supplemented with 118 mM NaCl, 5.8 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 1.4 mM NaH 2 PO 4 , 21.4 mM NaHCO 3 , and 11.1 mM glucose, was aerated with 95% O 2 and 5% CO 2 at 37°C. Prior to measurements, the wet weight of each tissue was determined. Western blot analysis. Isolated fresh tissues were treated under various conditions and then reactions were terminated by liquid nitrogen. Plasma membrane fractions for western blot analysis were prepared as described previously (Nobe et al., 2008) . Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed according to the method of Laemmli (Laemmli, 1970) , using a 12% polyacrylamide gel. Detection of each protein was performed in a similar manner as in our previous study (Nobe et al., 2010) using primary antibodies at 1:1000 dilution (polyclonal, Abcam Co., Cambridge, UK) followed by a horseradish peroxidase-conjugated secondary antibody (polyclonal IgG, Santa Cruz Biotechnology Inc., CA).
Measurement of isometric force development and intracellular calcium
Measurement of mRNA levels. Messenger RNA levels in each bladder tissue were measured as reported in our previous study (Saito et al., 2006) .
Data analysis.
Values are presented as the mean ± SEM obtained from at least five
animals. Statistical differences (p<0.01) for multiple comparisons were assessed with one-way analysis of variance for repeated measurements followed by the Student-Newman-Keuls test (Y-Stat Program; Igaku Tosyo Shuppan Co., Ltd., Tokyo, Japan).
Results
Basic characteristics of Adip-Sen mice. Plasma adiponectin levels were significantly increased (56.2%) in Adip-Sen mice compared with those in C57Bl mice at the age of 16-24 weeks, but body weight and the wet weight of bladder tissue were similar between the groups (Table 1) . Moreover, plasma glucose, total-Cho, PL, and FFA levels were also similar between the groups.
Changes in carbachol-induced bladder force development in Ca

2+
-free PSS.
Resting levels of isometric force in C57Bl and Adip-Sen mice bladders were 0.96 ± 0.05 and 1.11 ± 0.04 mN/mm 2 (n = 5), respectively. KCl (50 mM)-induced sustained force development was also similar between the groups (data not shown (Fig. 1 ). In the C57Bl mouse, a relationship was evident between R 340/380 and force development. The slope of this relation was 1.04. In the Adip-Sen mouse, the CCh-induced increase in force development was similar to the response in the C57Bl mouse, but it was detected at a lower R 340/380 compared with that in the C57Bl mouse.
Therefore, the slope of this relation in the Adip-Sen mouse was increased (2.57). inhibitor of calcium-dependent PKC (Fig. 3) . Pretreatment of the tissues with 1 µM Y27632 slightly reduced CCh-induced responses without affecting resting levels ( Fig.   3A ), but significant differences (p<0.01) between Adip-Sen and C57Bl mice remained, which were similar to the responses in the absence of Y27632. Pretreatment with 1 µM Gö6976 also slightly reduced force development in the C57Bl mouse (Fig. 3B ).
Effects of Rho kinase and protein kinase C (PKC) inhibitors on
However, the inhibitory effect of Gö6976 in Adip-Sen mice was significantly increased (p<0.01). In the presence of 1 µM Gö6976, 30 µM CCh-induced responses in C57Bl
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Changes in PKC isoforms in the Adip-Sen mouse bladder. To identify the distribution of PKC isoforms in mouse bladder smooth muscle, the expression of each isoform was assessed in C57Bl mice in the non-stimulated resting state (Fig. 4A) . The calcium-dependent PKC isoforms PKCα and PKCβ were detected, and calcium-independent PKC isoforms, PKCμ and PKCθ were also observed. The effect of PKCα and PKCβ expression on enhancement of adiponectin levels was assessed (Fig.   4B ). In the Adip-Sen mouse, we observed a significant increase (119%; p<0.01) in
PKCα levels compared with those in the C57Bl mouse, but they were not affected by addition of 30 µM CCh at 37°C for 5 min. Adiponectin levels and CCh treatment did not alter PKCβ, PKCμ, and PKCθ levels in C57Bl and Adip-Sen mice (data not shown).
To confirm an increase in protein levels in the Adip-Sen mouse, PKCα mRNA levels were also measured (Fig. 4C ). Relative PKCα mRNA levels in C57Bl and Adip-Sen mice were 0.011 ± 0.001 (n = 5) and 0.045 ± 0.003 (n = 5), respectively (p<0.01).
Significant increases in both PKCα protein and mRNA expression were confirmed in the Adip-Sen mouse.
Activation of PKC involves auto-phosphorylation of PKC in many types of cells (Stempka et al., 1999; Bayer et al., 2003) . In the non-stimulated resting state, phosphorylated-PKCα (p-PKCα) levels in C57Bl and Adip-Sen mice were not observed.
However, a 30 µM CCh-induced increase in p-PKCα levels was detected only in the Adip-Sen mouse (Fig. 4D ). This CCh-induced increase was 90.5% of resting levels (n = 5).
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Discussion
The current study found an association of adiponectin with bladder smooth muscle contraction. This finding suggested that this association was involved in activation of PKCα-mediated calcium dependency of bladder smooth muscle contraction.
To investigate the association between adiponectin and bladder smooth muscle contraction, we developed the Adip-Sen mouse, because changes in bladder function (s) by adiponectin might be detectable under conditions of chronically increased adiponectin levels. In the Adip-Sen mouse, increases in adiponectin levels were confirmed without affecting body weight and other blood parameters (Table 1) . These results are similar to our previous report (Saito et al., 2006) . Based on these results, we consider that changes in the Adip-Sen mouse were caused by chronically increased adiponectin levels, and these changes were not due to secondary effects in these transgenic mice. dependency in Adip-Sen mice is involved in receptor-mediated signaling systems, without involving enhancement of affinity between calcium and contractile proteins.
Intracellular calcium dependency of bladder contraction has been previously reported (Ekman et al., 2009; Nobe et al., 2009 ). However, changes in calcium dependency and its regulatory mechanism are not clearly understood. Therefore, we hypothesize that adiponectin is a regulatory factor of calcium sensitivity of bladder contraction.
In smooth muscle contraction, the Rho-Rho kinase pathway is one of the major However, we found that inhibitory effects of Gö6976 were significantly enhanced only in the Adip-Sen mouse (Fig. 3B ). These results indicate that the contribution of the PKC pathway in bladder contraction is enhanced in the Adip-Sen mouse. Therefore, we speculate that adiponectin regulates calcium dependency, which is mediated by activation of the PKC pathway.
We evaluated protein levels of PKC to examine the change in PKC with adiponectin-mediated increases in calcium dependency. It is generally accepted that PKC involves 10 or more isoforms, which involve calcium-dependent PKC (PKCα, β and γ), calcium-independent PKC (PKCδ, μ and θ), and atypical PKC isoforms (Salamanca and Khalil, 2005 ). In the current study, in bladder smooth muscle tissue, This article has not been copyedited and formatted. The final version may differ from this version.
PKCα, β, μ and θ isoforms were detected (Fig. 4A ). Among these isoforms, only PKCα was significantly enhanced, which depended on plasma adiponectin levels (Fig. 4B ).
These results indicate that calcium-dependent PKCα is chronically enhanced in the Adip-Sen mouse. Our results suggested that adiponectin enhanced PKCα expression and it increased calcium sensitivity of bladder contraction. Our findings of increased PKCα mRNA levels support this suggestion ( : : 2 9 2 -2 9 9 . :
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